A carregar...

Chimeric antigen receptor T cells with dissociated signaling domains exhibit focused anti-tumor activity with reduced potential for toxicity in vivo

Adoptive immunotherapy using lymphocytes genetically-modified to express a chimeric antigen receptor (CART) holds considerable promise for the treatment of cancer. However, CAR-based therapies may involve on-target toxicity against normal tissues expressing low amounts of the targeted tumor-associat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lanitis, Evripidis, Poussin, Mathilde, Klattenhoff, Alex W., Song, Degang, Sandaltzopoulos, Raphael, June, Carl H., Powell, Daniel J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3881605/
https://ncbi.nlm.nih.gov/pubmed/24409448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/2326-6066.CIR-13-0008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!